Fatal interstitial pneumonia in juvenile dermatomyositis

European Journal of Dermatology

Volumn 20, Issue 2, 2010, Pages 208-210

  Nagai, Yayoi ^a   Mizuno, Takahisa ^a   Yoshizawa, Chikage ^b   Ishikawa, Osamu ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Gunma Central General Hospital   (Japan)

Author keywords

Fatal outcome; Interstitial pneumonia; Juvenile dermatomyositis

Indexed keywords

CREATINE KINASE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FRUCTOSE BISPHOSPHATE ALDOLASE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE;

ARTICLE; CASE REPORT; CHILD; CREATINE KINASE BLOOD LEVEL; DERMATOMYOSITIS; DISEASE ASSOCIATION; FATALITY; FATIGUE; FEMALE; FEVER; HUMAN; INTERSTITIAL PNEUMONIA; LIVER DYSFUNCTION; MUSCLE WEAKNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPULE; PRESCHOOL CHILD; RASH; RESPIRATORY FAILURE;

CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; CYCLOSPORINE; DERMATOMYOSITIS; FATAL OUTCOME; FEMALE; FRUCTOSE-BISPHOSPHATE ALDOLASE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES, INTERSTITIAL; MAGNETIC RESONANCE IMAGING; METHYLPREDNISOLONE; MUSCLE, SKELETAL; PULSE THERAPY, DRUG;

EID: 77950451132     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2010.0846     Document Type: Article

References (22)

1. Stringer E, Singh-Grewal D, Feldman BM. Predicting the course of juvenile dermatomyositis. Arthritis Rheum 2008; 29: 3585-3592
2. Kim S, El-Hallak M, Dedeoglu F, Zurakowski D, Fuhlbrigge RC, Sundel RP. Complete and sustained remission of juvenile dermatomyositis from aggressive treatment. Arthritis Rheum 2009; 60: 1825-1830
3. Stringer E, Feldman BM. Advances in the treatment of juvenile dermatomyositis. Urr Opin Rheumatol 2006; 18: 503-506
4. Chari G, Laude TA. Juvenile dermatomyositis: a review. Int Pediatr 2000; 15: 21-25
5. Morinishi Y, Oh-ishi T, Kabuki T, Joh K. Juvenille dermatomyositis: clinical and the relatively high risk of interstitial lung disease. Mod Rheum 2007; 17: 413-417
6. Lin YC, Yang YH, Lin YT, Chiang BL. Steroid refractory interstitial pneumonitis in an patient with juvenile dermatomyositis. J Microbiol Immunol Infect 2002; 35: 259-261
7. Tosun A, Serdaroglu G, Aslan MT, et al. Severe juvenile dermatomyositis: two patients complicated with extra musculocutaneous involvement. Rheumatol Int 2006; 26: 1040-1043
8. Fudman EJ, Schnitzer TJ. Dermatomyositis without creatine kinase elevation. A poor prognostic sign. Am J Med 1986; 80: 329-332
9. Kashiwabara K, Ota K. Rapidly progressiveinterstitial lung disease in a dermatomyositis patient with high levels of creatine phospholonase, severe muscle symptoms and positive anti-Jo-1 antibody. Intern Med 2002; 41: 584-588
10. Nagai Y, Ishikawa O, Miyachi Y. Pneumomediastinum and subcutaneous emphysema associated with fatal interstitial pneumonia in dermatomyositis. J Dermatol 1997; 24: 482-484
11. Shibuya H, Arakawa S, Kai Y, et al. Three cases of 'mechanic's hands' associated with foot lesions. J Dermatol 2003; 30: 892-897
12. Kobayashi I, Ono S, Kawamura N, Okano M, Miyazawa K, Shibuya H, et al. KL-6 is a potential marker for interstitial lung disease associated with juvenile dermatomyositis. J Pediatr 2001; 138: 273-276
13. Matsushima Y, Nagai Y, Amano H, Ishikawa O. Juvenile Dermatomyositis Pract Dermatol 2006; 29: 524-530
14. Ramanan AV, Campbell-Webster N, et al. The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids. Arthritis Rheum 2005; 52: 3570-3578
15. Fisler RE, Liang MG, Fuhlbrigge RC, Yalcindag A, Sundel RP. Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. J Am Acad Dermatol 2002; 47: 505-511
16. Huber AM, Lang B, Leblanc CMA, Birdi N, Bolaria RK, Malleson P. Macneil I, et al. Medium and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 2000; 63: 541-549
17. Apaz MT, Saad-Magalhaes C, Pistorio A, Ravelli A, Sato JO, Marcantoni MB, et al. Health related quality of life of patients with juvenile dermatomyositis: results from the pediatric rheumatology international trials organization multinational quality of life cohort study. Arthritis Rheum 2009; 61: 509-517
18. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). New Engl J Med 1975; 292: 344-347
19. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). New Engl J Med 1975; 292: 403-407
20. Gardner-Medwin JMM, Irwin G, Johnson K. MRI in juvenilr idiopathic arthritis and juvenile dermatomyositis. Ann NY Acad Sci 2009; 1154: 52-83.
21. Kimball AB, Summers RM, Turner M, Dugan EM, Hicks J, Miller FW, et al. Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Arthritis Rheum 2000; 43: 1866-1873
22. Brown VE, Pilkington CA, Feldman BM, Davidson JE. An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM). Rheumatol 2006; 45: 990-993